Pentoxifylline to improve uterine lining and frozen embryo transfer outcomes
Official title: Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Run by Beni-Suef University · NCT07499817 · Data updated 2026-11-12
This trial sees if giving pentoxifylline alongside standard estradiol helps women with good-quality day‑5 frozen embryos get a thicker uterine lining and better frozen embryo transfer success.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 43 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Beni-Suef University Academic / other |
| Locations | 1 site (Banī Suwayf, Beni Suweif Governorate) |
| Status | Recruiting |
| Started | October 1, 2023 |
| Main results expected | April 1, 2026 |
| Study ends | April 30, 2026 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT07499817 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women about 18–43 years old with unexplained infertility who have good-quality day‑5 frozen embryos and no endocrine, significant cardiac/renal/hepatic disease or prior endometrial‑compromising surgery.
✕Probably not a fit
Patients with known endocrine disorders, significant cardiovascular/renal/hepatic disease, prior surgery that compromised the endometrium, or those not using day‑5 frozen embryos are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 3 randomized, parallel study enrolled 100 women aged 18–43 with good-quality day‑5 frozen embryos and unexplained infertility, randomized 1:1 to estradiol alone or estradiol plus pentoxifylline 400 mg daily. Endometrial thickness was measured by transvaginal ultrasound and frozen embryo transfer outcomes (implantation and pregnancy rates) were recorded. Treatment began on cycle day 1 and continued until the day progesterone was started; allocation used computer-generated randomization with sealed opaque envelopes. Patients with endocrine disease, prior surgeries that could compromise the endometrium, or significant cardiovascular, renal, or liver disease were excluded.
Why it matters
Potential benefit: If successful, adding pentoxifylline could increase endometrial thickness and improve implantation and pregnancy rates for women having frozen embryo transfers.
How similar studies have gone: Smaller prior studies of pentoxifylline and other vasodilators for endometrial thickness have reported mixed results, so the approach has some precedent but is not definitively proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * as good quality day five frozen embryos. Exclusion Criteria: * history of endocrine diseases, * history of any previous surgery that couldm compromise the integrity of endometrium, * cardiovascular, renal and liver diseases,
Where it's running
-
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Beni suef University — Beni-Suef University
- Study coordinator: Sara A Salem, MD
- Email: sara.abdalla@med.bsu.edu.eg
- Phone: 01272842226
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aromatherapy to support mental health in women undergoing IVF
This will test whether inhaling lavender oil twice daily can reduce anxiety, stress, and depression and improve quality of life for women awaiting IVF.
-
In vitro maturation of human eggs for fertility treatment
This study is testing a new way to help women with fertility issues by maturing their eggs in the lab with fewer hormones to see if it makes treatment easier and safer.
-
Comparing immediate and postponed embryo transfer for infertility treatment
This study is testing whether transferring an embryo right after egg retrieval is just as effective as waiting to transfer it later for helping people with infertility have a baby.
-
Examining discarded materials from IVF cycles to understand treatment outcomes
This study is trying to see if analyzing leftover materials from IVF cycles can help predict which treatments will be successful and improve the chances of pregnancy.
-
Selecting sperm for gender-specific offspring
This study is testing a new way to choose sperm based on whether it carries an X or Y chromosome to help couples undergoing infertility treatment have a baby of a specific gender.
-
Analyzing cervical mucus to identify markers for endometrial receptivity in infertility treatment
This study is testing if analyzing proteins in cervical mucus can help doctors find out which patients are more likely to have successful embryo transfers during infertility treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.